US Patent 11229702 High concentration formulations of adalimumab
Patent 11229702 was granted and assigned to Coherus BioSciences on January, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 28, 2016
Date of Patent
January 25, 2022
Patent Applicant
Patent Application Number
15337519
Patent Citations
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11229702 High concentration formulations of adalimumab
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
